首页 | 本学科首页   官方微博 | 高级检索  
     

人源间变性大细胞淋巴瘤BALB/c小鼠建模的免疫学机制
引用本文:牟东云,陆静,张燕,白雪芹,邓飞. 人源间变性大细胞淋巴瘤BALB/c小鼠建模的免疫学机制[J]. 遵义医学院学报, 2014, 0(4): 409-411
作者姓名:牟东云  陆静  张燕  白雪芹  邓飞
作者单位:遵义医学院病理学教研室,贵州遵义563099
基金项目:国家自然科学基金资助项目(NO:81160300).
摘    要:目的 建立人源间变性大细胞淋巴瘤(ALCL) BALB/c小鼠模型,探讨成瘤的免疫学机制.方法 BALB/c小鼠环磷酰胺(CTX)预处理,Karpas-299细胞右腋下注射;流式细胞术检测各组小鼠外周血淋巴细胞亚群比例.结果 ①成功建立人源间变性大细胞淋巴瘤BALB/c小鼠模型.②成瘤组与CTX组相比,CD3+、CD8+和CD19+细胞减少(P<0.05);未成瘤组与CTX组相比,CD8+、CD19+细胞减少,CD20+细胞增多(P<0.05);成瘤组CD3+、CD8+细胞较CTX组和未成瘤组均减少(P<0.05);未成瘤组CD20+细胞较CTX组和成瘤组均增多(P<0.05).③注射CTX第3天,BALB/c小鼠CD3+细胞增多,CD19+细胞减少(P<0.05);第10天CD8+、CD19+、CD20+细胞较注射CTX前减少(P<0.05);第17天和第24天,CD8+、CD19+、CD20+细胞仍低于注射CTX前(P<0.05),但较第10天有逐渐回升趋势(P>0.05).结论 CTX所致机体免疫抑制在ALCL成瘤起始阶段起决定性作用,ALCL的生长可能与CD3+、CD8+细胞减少有关.

关 键 词:间变性大细胞淋巴瘤  BALB/c小鼠  Karpass-299  环磷酰胺  肿瘤免疫

Immunosuppression and establishment of anaplastic large cell lymphoma in BALB/c mouse model
Mu Dongyun,Lu Jing,Zhang Yan,Bai Xueqin,Deng Fei. Immunosuppression and establishment of anaplastic large cell lymphoma in BALB/c mouse model[J]. Acta Academiae Medicine Zunyi, 2014, 0(4): 409-411
Authors:Mu Dongyun  Lu Jing  Zhang Yan  Bai Xueqin  Deng Fei
Affiliation:(Department of Pathology ,Zunyi Medical University, Zunyi Guizhou 563099, China)
Abstract:Objective To establish the BALB/c mouse model with human anaplastic large cell lymphoma (ALCL), and to explore the immunological mechanisms of tumor formation. Methods With the Cytoxan (CTX) pretreatment, Karpas -299 cells were injected to armpits for building model. Peripheral blood was collected to detect T and B lymphocyte subgroup proportion by flow cytometry. Results 1 )The BALB/c mouse models bearing human ALCL were successfully established. 2 ) In tumor group, CD3 + , CD8 + , CD19 + cells were significantly reduced than that of the control group ( P 〈 0.05 ) ; In group without tumor, CD8 + , CD19 + cells were fewer, CD20+ cells were increased than that of the control group (P 〈 0.05 ) ; In tumor group, compared with the control group and the group without tumor, CD3 + , CD8 + cells were significantly reduced (P 〈0.05 ) ; In the group without tumor, compared with the control group and the tumor group, CD20 + cells was significantly increased ( P 〈 0.05). 3) In CTX control group, on third day, compared with before the injection of CTX , the proportion of CD3 + cells was increased, the proportion of CD19 + cells was decreased; On the tenth day,the decline in percentage of CD8 + , CD19 + , CD20 + cells was significant (P 〈 0.05 ) ; On the 17th and 24th days, CD8 + , CD19 + , CD20 + cells ratio was still lower than before the injection of CTX( P 〈 0.05 ), but there was gradually up ward trend compared with the 10th day (P 〉 0. 05 ). Conclusion Immunosuppression caused by CTX plays a determinant role in the beginning of tumor formation ; The rapid growth of the tumor may be associated with the decreased CD3 + and CD8 + cells.
Keywords:ALCL  BALB/c mice  Karpas - 299  cytoxan  tumor immunity
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号